1/30
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
proteins of the complement system are part of
innate immunity
characteristic of complement
plays a role in the lysis of target cells coated with specific antibodies
complement is essential for our body’s response to infection by bein heavily involved in
inflammation
which complement component is found in both classical and alternative pathways
C3
which can activate the alternative complement pathway
C3b
what is the correct order of activation of complement in the lectin activation
MBL, C4, C2, C3
the lectin pathway is initiated by the presence of
Mannose
The recognition unit in the classical complement pathway consists of
C4b2a3b
Which immunoglobulin can activate complement
IgM
what functions by inserting itself into target membranes and forming channels or holes in the membranes
C5b6789
C5 convertase of the alternative pathway of complement activation is
C3bBb3bP
C5b6789 function is
target cell lysis
what acts as an opsonin
C3b
which complement protein is the key intermediate in all complement pathways
C3
which complement components has chemotactic activity
C3a
the alternative and classical pathway C3 convertases are destabilized as a means of downregulating complement function. One molecule that performs this function is
membrane cofactor protein
formation of the membrane attack complex (C5-C9) is stopped by which factor
S protein
which factor must be associated with factor H to inactivate complement components
Factor 1
Lack of complement components C5 through C9 may result in what condition
Neisseria infection
Dense deposits of C3 breakdown products can accumulate in the kidneys because of
autoantibodies that bind C3bBb
lack of the complement inhibitor C11NK results in what disease
Hereditary Angioedema
Kidney glomeruli can become obstructed with immune complexes as a result of
inadequate C3b-mediated opsonization
what complement therapeutics targets the classical pathway
C1-INH
antibodies targeting C1’s as therapy for cold agglutinin autoimmune hemolytic anemia would cause
high CH50
what reagent is present in a CH50 assay and absent in AH50 assay
red blood cells
decreased Ch50 and a decreased AH50 would indicate a low amount of which complement components
C3
test that could be used to determine whether a patient has a specific deficiency in C3
radial immunodiffusion
patient has an abnormal alternative pathway activation patter. what complement proteins should be assessed to further investigate the problem
C3
a normal CH50 and low AH50 may indicate
alternative pathway deficiency issues
patients undergoing treatment with complement therapeutics for hereditary angioedema (HAE) would expect to ahve what laboratory values
increased C4 and C2
therapeutics targeting the alternative pathways typically cause
decreased AH50